首页 | 本学科首页   官方微博 | 高级检索  
     


Chromosomal radiosensitivity of human breast carcinoma cells and blood lymphocytes following photon and proton exposures
Authors:Kowalska  Agata  Nasonova  Elena  Kutsalo  Polina  Czerski  Konrad
Affiliation:1.Institute of Mathematics, Physics and Chemistry, Maritime University of Szczecin, Wa?y Chrobrego 1, 2, 70-500, Szczecin, Poland
;2.Joint Institute for Nuclear Research, Joliot-Curie 6, 141980, Dubna, Russia
;3.Institute of Physics, University of Szczecin, ul. Wielkopolska 15, 70-451, Szczecin, Poland
;
Abstract:

Breast carcinomas (BC) are among the most frequent cancers in women. Studies on radiosensitivity and ionizing radiation response of BC cells are scarce and mainly focused on intrinsic molecular mechanisms but do not include clinically relevant features as chromosomal rearrangements important for radiotherapy. The main purpose of this study was to compare the ionizing radiation response and efficiency of repair mechanisms of human breast carcinoma cells (Cal 51) and peripheral blood lymphocytes (PBL) for different doses and radiation qualities (60Co γ-rays, 150 MeV and spread-out Bragg peak (SOBP) proton beams). The radiation response functions obtained using the conventional metaphase assay and premature chromosome condensation (PCC) technique enabled us to determine the number of chromosomal breaks at different time after irradiation. Both cytogenetic assays used confirmed the higher biological radiosensitivity for proton beams in tumor cells compared to PBL, corresponding to higher values of the linear LQ parameter α. additionally, the ratio of the LQ parameters β/α describing efficiency of the repair mechanisms, obtained for chromosome aberrations, showed higher numbers for PBL than for Cal 51 for all exposures. Similar results were observed for the ratio of PCC breaks determined directly after irradiation to that obtained 12 h later. This parameter (t0/t12) showed faster decrease of the repair efficiency with increasing LET value for Cal 51 cells. This finding supports the use of the proton therapy for breast cancer patients.

Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号